IIT-B scientist gets nod to launch algo-based Covid-19 testing tool

Called Tapestry, the new testing tool is developed by the startup launched by IIT-Bombay professor Manoj Gopalkrishnan.

Coronavirus mutation, coronavirus strain, coronavirus variant
Photo: Shutterstock
Press Trust of India Mumbai
3 min read Last Updated : Jun 22 2021 | 6:06 PM IST

Bengaluru-based tech startup Algorithmic Biologics has received regulatory approvals to launch its COVID-19 testing method that can help scale up testing for the deadly virus infection at half the prevailing cost and one-tenth of the time.

Called Tapestry, the new testing tool is developed by the startup launched by IIT-Bombay professor Manoj Gopalkrishnan.

It enables the safe reopening of places of work and education as it is affordable and can be used frequently using a single round quantitative pooling algorithm with the gold-standard RT-PCR test, the professor who teaches machine learning at the IIT- Bombay told PTI on Tuesday from Hyderabad.

Gopalkrishnan said Tapestry, which has been under development since last March, has just been cleared by the Drugs Controller General (DCGI) for commercial use as a non-regulated medical device and has also been registered with the Central Drugs Standard Control Organization.

The professor said he has tied up with two labs for the testing -- Delhi-based LabAssure and Bengaluru-based Dhitiomics for commercial use and is in talks with many other labs for a nationwide launch.

Tapestry lowers testing time to four hours, which is just a tenth of the present time taken by the traditional RT-PRC tests, while the cost is under 50 per cent of the lowest such test at around Rs 250, he said.

The tool has undergone sampling tests on over 8,000 people since last July at the Institute for Stem Cell Science & Regenerative Medicine, Bengaluru, and the Centre for Cellular & Molecular Biology in Bengaluru.

Clinical trials were carried out at Tata Memorial Centre from last August, while field trials were held on the students of the International Institute of Information Technology in Hyderabad from this February, said Gopalkrishnan.

He has a PhD from the University of Southern California and electrical engineering from IIT Kharagpur and has been teaching at the IIT-Bombay since 2008.

Tapestry, also validated by Harward Medical School, was invented at the IIT-B and taken forward with the help of leading research institutions like the National Centre for Biological Sciences, Institute for Stem Cell Science & Regenerative Medicine, Tata Memorial Centre, Centre for Cellular & Molecular Biology and a few reputed international research labs.

The tool works like a compression algorithm for molecular testing and uses samples from different individuals, which are mixed into pools using a code.

Each sample is sent to three pools, ensuring testing in triplicate and accurate results. Individual-level results are recovered by looking at the pattern of the pooling results and applying a decoding algorithm, said the 40-year-old professor.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusIIT-BCoronavirus Vaccine

First Published: Jun 22 2021 | 6:05 PM IST

Next Story